Lyell Immunopharma Stock Price on December 13, 2024
| LYEL Stock | USD 0.67 0.09 11.84% |
If you're considering investing in Lyell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lyell Immunopharma stands at 0.67, as last reported on the 14th of December 2024, with the highest price reaching 0.76 and the lowest price hitting 0.65 during the day. Lyell Immunopharma has Sharpe Ratio of -0.0973, which conveys that the firm had a -0.0973% return per unit of risk over the last 3 months. Lyell Immunopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lyell Immunopharma's Risk Adjusted Performance of (0.05), mean deviation of 5.17, and Standard Deviation of 7.18 to check out the risk estimate we provide.
At this time, Lyell Immunopharma's Stock Based Compensation To Revenue is quite stable compared to the past year. . The value of Price To Sales Ratio is estimated to slide to 2,378. The value of Price Earnings Ratio is estimated to slide to -2.18. Lyell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lyell |
Sharpe Ratio = -0.0973
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LYEL |
Estimated Market Risk
| 7.23 actual daily | 64 64% of assets are less volatile |
Expected Return
| -0.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lyell Immunopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lyell Immunopharma by adding Lyell Immunopharma to a well-diversified portfolio.
Price Book 0.4185 | Enterprise Value Ebitda 0.251 | Price Sales 3.9 K | Shares Float 203.6 M | Wall Street Target Price 2 |
Lyell Immunopharma Main Headline on 13th of December 2024
Lyell Immunopharma is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Lyell Immunopharma Valuation on December 13, 2024
It is possible to determine the worth of Lyell Immunopharma on a given historical date. On December 13, 2024 Lyell was worth 0.76 at the beginning of the trading date compared to the closed value of 0.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lyell Immunopharma stock. Still, in general, we apply an absolute valuation method to find Lyell Immunopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lyell Immunopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lyell Immunopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.83 | 0.85 | 0.75 | 0.76 | 1,804,138 | |
12/13/2024 | 0.76 | 0.76 | 0.65 | 0.67 | 2,947,520 |
| Backtest Lyell Immunopharma | | | Lyell Immunopharma History | | | Lyell Immunopharma Valuation | Previous |
Lyell Immunopharma Trading Date Momentum on December 13, 2024
| On December 13 2024 Lyell Immunopharma was traded for 0.67 at the closing time. The top price for the day was 0.76 and the lowest listed price was 0.65 . The trading volume for the day was 2.9 M. The trading history from December 13, 2024 did not cause price change. The trading delta at closing time against the current closing price is 13.43% . |
Lyell Immunopharma Fundamentals Correlations and Trends
By evaluating Lyell Immunopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lyell Immunopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lyell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lyell Immunopharma Stock history
Lyell Immunopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lyell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lyell Immunopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lyell Immunopharma stock prices may prove useful in developing a viable investing in Lyell Immunopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 251 M | 271.5 M | |
| Net Loss | -164.8 M | -173 M |
Lyell Immunopharma Quarterly Net Working Capital |
|
Lyell Immunopharma Stock Technical Analysis
Lyell Immunopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lyell Immunopharma Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Lyell Immunopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lyell Immunopharma December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Lyell Immunopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lyell Immunopharma shares will generate the highest return on investment. By undertsting and applying Lyell Immunopharma stock market strength indicators, traders can identify Lyell Immunopharma entry and exit signals to maximize returns
Lyell Immunopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lyell Immunopharma's price direction in advance. Along with the technical and fundamental analysis of Lyell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lyell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Quarterly Revenue Growth 0.36 | Return On Assets (0.19) | Return On Equity (0.33) |
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.